Retractable Technologies (NYSE:RVP) Now Covered by Analysts at StockNews.com

StockNews.com started coverage on shares of Retractable Technologies (NYSE:RVP) in a research note published on Monday. The brokerage issued a hold rating on the stock.

Retractable Technologies Trading Down 7.7 %

Shares of RVP opened at $0.75 on Monday. The company has a debt-to-equity ratio of 0.01, a quick ratio of 5.92 and a current ratio of 8.57. Retractable Technologies has a 52-week low of $0.56 and a 52-week high of $1.34. The firm has a market cap of $22.52 million, a price-to-earnings ratio of -1.39 and a beta of 1.94. The business’s fifty day moving average is $0.66 and its 200-day moving average is $0.85.

Institutional Trading of Retractable Technologies

A hedge fund recently bought a new stake in Retractable Technologies stock. PFG Investments LLC purchased a new position in shares of Retractable Technologies, Inc. (NYSE:RVP) in the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The firm purchased 34,600 shares of the company’s stock, valued at approximately $27,000. PFG Investments LLC owned about 0.12% of Retractable Technologies as of its most recent filing with the SEC. Institutional investors and hedge funds own 7.58% of the company’s stock.

Retractable Technologies Company Profile

Retractable Technologies, Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes.